Search research articles
Contact Us
Filters
Showing results (31-40 of 558) with videos related to
Page
of 56
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1994
Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists
F Noble, C Smadja, B P Roques
Journal of Neurochemistry
|
January 1, 1997
Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites
I Léna, B P Roques, C Durieux
Neuroscience Letters
|
June 25, 1993
RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats
R Maldonado, D Girdlestone, B P Roques
Neuropharmacology
|
June 1, 1994
Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices
M Migaud, B P Roques, C Durieux
Biochimie
|
January 1, 1980
Use of nuclear Overhauser effect in the study of peptides and proteins
B P Roques, R Rao, D Marion
Psychopharmacology
|
January 1, 1989
Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors
V Daugé, P Rossignol, B P Roques
British Journal of Pharmacology
|
March 1, 1994
Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole
M Derrien, C Durieux, B P Roques
Journal of Biomolecular Structure & Dynamics
|
December 1, 1989
Intercalative binding of ditercalinium to d(CpGpCpG)2: a theoretical study
R Maroun, M Delepierre, B P Roques
NIDA Research Monograph
|
January 1, 1986
Enkephalin degrading enzyme inhibitors: a physiological way to new analgesics and psychoactive agents
B P Roques, M C Fournie-Zaluski
European Journal of Biochemistry
|
March 14, 1991
Functional residues at the active site of aminopeptidase N
A Helene, A Beaumont, B P Roques
Page
of 56
Search research articles
Search
Showing results (31-40 of 558) with videos related to
Sort By:
Page
of 56
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1994
Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists
F Noble, C Smadja, B P Roques
Journal of Neurochemistry
|
January 1, 1997
Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites
I Léna, B P Roques, C Durieux
Neuroscience Letters
|
June 25, 1993
RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats
R Maldonado, D Girdlestone, B P Roques
Neuropharmacology
|
June 1, 1994
Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices
M Migaud, B P Roques, C Durieux
Biochimie
|
January 1, 1980
Use of nuclear Overhauser effect in the study of peptides and proteins
B P Roques, R Rao, D Marion
Psychopharmacology
|
January 1, 1989
Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors
V Daugé, P Rossignol, B P Roques
British Journal of Pharmacology
|
March 1, 1994
Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole
M Derrien, C Durieux, B P Roques
Journal of Biomolecular Structure & Dynamics
|
December 1, 1989
Intercalative binding of ditercalinium to d(CpGpCpG)2: a theoretical study
R Maroun, M Delepierre, B P Roques
NIDA Research Monograph
|
January 1, 1986
Enkephalin degrading enzyme inhibitors: a physiological way to new analgesics and psychoactive agents
B P Roques, M C Fournie-Zaluski
European Journal of Biochemistry
|
March 14, 1991
Functional residues at the active site of aminopeptidase N
A Helene, A Beaumont, B P Roques
Page
of 56